Evgen Pharma plc (EVG) Ordinary 0.25p
0.1p
(1.32%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.1p
(1.32%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA,
SIPP or
Fund and Share Account
0.1p
(1.32%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA,
SIPP or
Fund and Share Account
7.55p
7.59p
28.50p
£9.88 million
7.55p
7.30p
5.50p
n/a
0.10p (1.34%) Previous:
0.10p
61,393
n/a
5,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/03/2019 | 31/03/2018 |
|---|---|---|
| Revenue (£m) | n/a | n/a |
| Profit before tax (£m) | (3.12) | (3.03) |
| Adjusted EPS (p): | (2.74) | (3.28) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
To buy shares in , you'll need to have an account. Try our handy filter to explore the different options.
Ready to take your first step?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
There are no documents available for this stock.
Broker forecasts
-
Strong Sell
(0 of 1) -
Sell
(0 of 1) -
Neutral
(1 of 1) -
Buy
(0 of 1) -
Strong Buy
(0 of 1)
This is not a recommendation, it represents the consensus view of a basket of brokers. If fewer than 5 brokers it may not be a valid consensus. HL might not concur and takes no responsibility.
Full broker forecasts-
Evgen Pharma to advance SFX-01 trial with University of Dundee
5 December 2019 16:36
-
Evgen Pharma upbeat on latest news from SFX-01 studies
23 September 2019 10:03
-
Evgen Pharma completes patient study visits in 'SAS' phase 2 trial
28 August 2019 14:30
-
MOU with The University of Dundee
5 December 2019 07:00
-
Notice of Results
4 December 2019 15:11
-
Holding(s) in Company
14 November 2019 11:59
| Time / date Time | Buy / sell Type | Volume | Price | Value |
|---|
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled ‘N/A’.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA,
SIPP or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.